Skip to main content

Post-IPO Debt Biotechnology Companies

Explore 90 biotechnology startups that raised post-ipo debt funding. Access verified founder contact information and fundraising data.

Total Companies
90
Total Funding
$5.8B
Avg Funding
$233.4M
Cities
18

Export 90 Post-IPO Debt Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
San Carlos, United States
$575.0M
raised

Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.

Oct 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Florham Park, United States
$10.0M
raised

Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.

Sep 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$400.0M
raised

Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.

Sep 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$50.0M
raised

Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.

Jul 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$105.0M
raised

Spero Therapeutics develops therapeutics for treatment of gram-negative infections.

Jul 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 90 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Alpharetta, United States
$3.0M
raised

Clearside BioMedical is an ophthalmic company that specializes in the research, development, and commercialization of therapeutic products.

Jul 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$2.1M
raised

Gemina Labs is a transformative biochemistry firm that develops next-generation testing platforms for detecting pathogens.

Jul 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

New York, United States
$125.0M
raised

MeiraGTx is a biotechnology company that focuses on developing gene therapies to treat inherited and acquired genetic disorders.

Jul 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Holland, United States
$45.0M
raised

Shoulder Innovations is a medical device company that develops inset glenoid fixation technology.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Emeryville, United States
$200.0M
raised

4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 90 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Emeryville, United States
$200.0M
raised

4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Emeryville, United States
$200.0M
raised

4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Emeryville, United States
$200.0M
raised

4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$10.0M
raised

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

New York, United States
$250.0M
raised

Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 90 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Allschwil, Switzerland
$313.9M
raised

The purpose of Idorsia is to discover, develop and commercialize innovative medicines to help more patients.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

San Diego, United States
$150.0M
raised

Maravai is a life sciences company providing critical products to enable the development of drug therapies, diagnostics, novel vaccines.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Hamel, United States
$500.0M
raised

Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Radnor, United States
$500.0M
raised

Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$1.3B
raised

Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.

May 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 90 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Gaithersburg, United States
$50.0M
raised

Pioneering Potent, Safer Cell Therapy in and Beyond Oncology

May 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Saskatoon, Canada
$505K
raised

ZYUS is a biopharmaceutical company that offers patients cannabinoid and other phyto-therapeutic medical solutions.

May 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$10.0M
raised

Senti Bio is a clinical-stage biotechnology company developing a new generation of cell and gene therapies for cancer.

May 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Foster City, United States
$600.0M
raised

Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.

May 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

New Hope, United States
$35.0M
raised

Orchestra BioMed is a biomedical innovation company that provides high-impact solutions for large unmet needs in procedure-based medicine.

May 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Showing 1 to 25 of 90 companies

Ready to Connect with Post-IPO Debt Biotechnology Startups?

Get verified founder emails, funding details, and company data for 90 post-ipo debt biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked